Lataa...
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
The treatment of chronic hepatitis B is in constant evolution. Interferon, the first agent licensed for chronic hepatitis B treatment, has been superseded by the growing popularity of nucleoside/nucleotide analogues (NA). However, resistance to these agents is a major challenge. Newer NAs, such as e...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Current Science Inc.
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3210946/ https://ncbi.nlm.nih.gov/pubmed/22131901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-011-0109-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|